6-METHYL-1,1-DIOXO-2,3-DIHYDRO-1H-1LAMBDA6-IMIDAZO[2,1-B]THIAZOLE-5-CARBOXYLIC ACID PYRIDIN-2-YLAMIDE


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	ATAVNYMORCRVJT-UHFFFAOYSA-N
Smiles	Cc1nc2n(CCS2(=O)=O)c1C(=O)Nc3ccccn3
InChI	InChI=1S/C12H12N4O3S/c1-8-10(11(17)15-9-4-2-3-5-13-9)16-6-7-20(18,19)12(16)14-8/h2-5H,6-7H2,1H3,(H,13,15,17)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C12H12N4O3S
Molecular Weight	292.31
AlogP	0.56
Hydrogen Bond Acceptor	5.0
Hydrogen Bond Donor	1.0
Number of Rotational Bond	2.0
Polar Surface Area	102.33
Molecular species	NEUTRAL
Aromatic Rings	2.0
Heavy Atoms	20.0

Assay Description	Organism	Bioactivity	Reference
Fungicidal activity against Phaeosphaeria nodorum inoculated in 24 hr compound-treated plant foliage assessed as disease control at 200 ppm measured after 7 days	Phaeosphaeria nodorum	0.0 %
Fungicidal activity against Oculimacula yallundae inoculated in 24 hr compound-treated plant foliage assessed as disease control at 200 ppm measured after 7 days	Oculimacula yallundae	100.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2289771
PubChem	50878415

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

6-METHYL-1,1-DIOXO-2,3-DIHYDRO-1H-1LAMBDA*6*-IMIDAZO[2,1-B]THIAZOLE-5-CARBOXYLIC ACID PYRIDIN-2-YLAMIDE

Structure

Physicochemical Descriptors

Cross References

6-METHYL-1,1-DIOXO-2,3-DIHYDRO-1H-1LAMBDA6-IMIDAZO[2,1-B]THIAZOLE-5-CARBOXYLIC ACID PYRIDIN-2-YLAMIDE